Innovating preclinical research
Capabilities
Leveraging advanced techniques to deliver precise, high-quality solutions in metabolic research.
Obesity - Metabolic syndrome
Preclinical services for obesity and metabolic disorders, focusing on mechanisms and drug efficacy.
DESCRIPTION:
At Albor Biotech, we are specialized in providing comprehensive services for preclinical studies of obesity and metabolic disorders. We offer invaluable support to scientists and medical researchers, with our core expertise lying in the development and utilization of in vitro and in vivo models.
Our focus on obesity and metabolic diseases extends beyond their physical manifestation, inquiring about the molecular and cellular processes. We offer several animal models of obesity and metabolic disorders to study the physiological changes and underlying mechanisms. Our integrative approach provides mechanistic understanding of your drug candidates’ efficacy for better translation to the clinical setting and help to bring new therapies to the light.
Diabetes - Insulin resistance
Preclinical services for insulin resistance and type 2 diabetes using advanced models.
DESCRIPTION:
Albor Biotech offers preclinical CRO services using innovative and benchmarked animal models of obesity, insulin resistance and type 2 diabetes to study the effects of potential new therapies.
Our clients benefit from our experts’ capabilities, which include classical in vivo test experiments (GTT, ITT, tissue-specific insulin sensitivity, GSIS, etc.) and our gold standard tracer- based experiments: euglycemic – hyperglycemic – hyperinsulinemic clamp with 3H-glucose (for glucose turnover, hepatic glucose production, etc.) and 14C-2-deoxyglucose (for glucose tissue uptake in insulin-sensitive organs).
Steatosis - Hepatic fibrosis
Preclinical services for NASH/MASH and hepatic fibrosis using specialized liver models.
DESCRIPTION:
The increase in the global prevalence of NASH/MASH (Non-Alcoholic Steatohepatitis, Metabolic Dysfunction Associated SteatoHepatitis) has turned into an epidemic, urgently requiring effective therapies. At Metabotech, we are dedicated to advancing liver research and understanding the complexities of the hepatic system through comprehensive in vivo and in vitro liver models, histology, and bioanalysis services.
Metabotech provides high quality NASH/MASH preclinical CRO services in order to help clients develop new treatments for NASH/MASH and liver fibrosis. With extensive experience in preclinical studies, safety and efficacy, we have developed specialized models that focus on the liver, providing invaluable insights into the effects of compounds on hepatic function.
Oncology
Albor Biotech offers oncology preclinical CRO services to evaluate your drugs targeting this pathology. Combined with our in vitro experiments, and using Fluorescence-Activated Cell Sorting (FACS) analyses, we validate the efficacy of your treatment.
DESCRIPTION:
We offer xenograft experiments in immunodeficient mice using tumor cell lines with the aim of generating tumors for studies of tumor initiation capacity, tumor growth assessment, pharmacological efficacy studies and survival rate evaluation.
Besides in vivo experiments and translatable biomarkers, our clients benefit from our complete histology and cytometry services panel and histopathology scoring to fully characterize cancer.
Our experience and our expertise as consultancy services will optimize and accelerate your drug development program for cancer complications.
Behavior
Preclinical behavioral services focusing on stress, memory, and motor skills to evaluate therapeutic potential.
DESCRIPTION:
We offer a diverse range of tests focused on stress, memory and learning, movility, agility, endurance and dexterity tailored to address the industry’s needs.
Our behavioral CRO specializes in delivering reliable and robust preclinical insights into the underlying mechanisms of behavior. This enables researchers to explore behavior mechanisms and evaluate the potential of therapeutics and drug development effectively.
Nutraceutics
Preclinical evaluation of nutraceuticals targeting metabolic disorders using specialized mouse models.
DESCRIPTION:
Preclinical evaluation of the beneficial effects of nutraceuticals is a mandatory step to develop such treatments. Metabotech offers nutraceuticals preclinical studies to evaluate your products (drugs, vegetal extracts, prebiotics and probiotics) targeting obesity, insulin resistance, type 2 diabetes and related metabolic disorders using our benchmarked mouse models.
Our expertise spanning over 15 years enables us to deliver reliable results and assist our clients in reducing the time to market for their newly developed nutraceuticals.
Animal health
Preclinical services for animal health, evaluating pharmacological treatments and nutrition effects on metabolism and well-being.
DESCRIPTION:
Our CRO service specialized in animal nutrition is designed to elucidate the effectiveness of pharmacological treatments on the health of both domestic and farming animals, evaluating the effect they have on the control of body weight, appetite, and carbohydrate and lipid metabolism. The effect of different animal feeds or foods in development phase on the metabolism and general well-being of the animal is also evaluated.
Consultancy
Expert consultancy services providing guidance and tailored solutions for development programs and experimental designs.
DESCRIPTION:
The quality of our work is driven by the expertise of our team, whose qualifications are supported by over 300 scientific publications that validate our findings and methods. This provides a valuable source of advice and guidance for our clients with their development programs, creating scientific approaches or experimental designs specifically based on a comprehensive array of differentiated services to be applied according to the needs of each client.
We combine our core values of personalized customer service, flexibility, and scientific innovation, to provide a consistently superior service.
